Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome
暂无分享,去创建一个
[1] Xiaolong He,et al. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia , 2020, Critical Care.
[2] P. Seth,et al. ‘Primed’ Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients , 2020, Stem Cell Reviews and Reports.
[3] S. Terai,et al. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases , 2020, Inflammation and regeneration.
[4] Hua Qin,et al. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics , 2020, Protein & Cell.
[5] Shaoda Ren,et al. Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia , 2020, Stem Cell Research & Therapy.
[6] Fu-Sheng Wang,et al. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients , 2020, Journal of Translational Medicine.
[7] V. Sengupta,et al. Exosomes Derived From Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19. , 2020, Stem cells and development.
[8] L. O’Driscoll,et al. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment , 2020, Drug Discovery Today.
[9] Shan Liu,et al. Mesenchymal stem cells as a potential therapy for COVID-19 , 2020, Stem Cell Research & Therapy.
[10] Koichi Yuki,et al. COVID-19 pathophysiology: A review , 2020, Clinical Immunology.
[11] David Berlin,et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases , 2020, Translational Research.
[12] A. Ardeshirylajimi,et al. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future , 2020, Stem Cell Reviews and Reports.
[13] Subha Ghosh,et al. COVID-19 Autopsies, Oklahoma, USA , 2020, American journal of clinical pathology.
[14] S. Xiao,et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies , 2020, Modern Pathology.
[15] C. Caruso,et al. Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia , 2020, Aging and disease.
[16] L. Manchikanti,et al. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use. , 2020, Pain physician.
[17] Haibo Xu,et al. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer , 2020, Journal of Thoracic Oncology.
[18] M. Letko,et al. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.
[19] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.
[20] J. Guarner. Three Emerging Coronaviruses in Two Decades , 2020, American journal of clinical pathology.
[21] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[22] E. Haddad,et al. Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped Lentivector , 2019, Front. Immunol..
[23] S. Meng,et al. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury , 2019, Stem Cell Research & Therapy.
[24] Sang-Bum Hong,et al. The effect of human adipose-derived stem cells on lipopolysaccharide-induced acute respiratory distress syndrome in mice. , 2019, Annals of translational medicine.
[25] C. D. dos Santos,et al. Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology , 2019, Stem cells international.
[26] L. Cancio,et al. Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome , 2019, Stem cells translational medicine.
[27] S. Xiao,et al. IL-10 Gene-Modified Human Amniotic Mesenchymal Stem Cells Augment Regenerative Wound Healing by Multiple Synergistic Effects , 2019, Stem cells international.
[28] Tingting Yang,et al. Nrf2/Keap1/ARE Signaling Mediated an Antioxidative Protection of Human Placental Mesenchymal Stem Cells of Fetal Origin in Alveolar Epithelial Cells , 2019, Oxidative medicine and cellular longevity.
[29] Kuang-Yao Yang,et al. Mesenchymal Stem Cell-Conditioned Medium Induces Neutrophil Apoptosis Associated with Inhibition of the NF-κB Pathway in Endotoxin-Induced Acute Lung Injury , 2019, International journal of molecular sciences.
[30] B. Lopresti,et al. Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model , 2019, BMJ Open Respiratory Research.
[31] F. Gao,et al. Mesenchymal stem cells with downregulated Hippo signaling attenuate lung injury in mice with lipopolysaccharide-induced acute respiratory distress syndrome , 2018, International journal of molecular medicine.
[32] Li Yan,et al. Mesenchymal stem cells derived from human pluripotent cells, an unlimited and quality‐controllable source, for therapeutic applications , 2018 .
[33] Jeonghyun Park,et al. Therapeutic use of mesenchymal stem cell–derived extracellular vesicles in acute lung injury , 2018, Transfusion.
[34] Huipeng Chen,et al. LncRNA analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models. , 2018, International immunopharmacology.
[35] H. Goldschmidt,et al. Cell-based immunotherapy approaches for multiple myeloma , 2018, British Journal of Cancer.
[36] M. Dehghan,et al. Intrapulmonary autologous transplant of bone marrow-derived mesenchymal stromal cells improves lipopolysaccharide-induced acute respiratory distress syndrome in rabbit , 2018, Critical Care.
[37] L. Cancio,et al. Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease , 2018, Respiratory Research.
[38] A. Putra,et al. The Role of TNF-α induced MSCs on Suppressive Inflammation by Increasing TGF-β and IL-10 , 2018, Open access Macedonian journal of medical sciences.
[39] Yanbin Zhao,et al. Transcriptomic analysis of lung tissues after hUC‐MSCs and FTY720 treatment of lipopolysaccharide‐induced acute lung injury in mouse models , 2018, International immunopharmacology.
[40] C. Bai,et al. Lung-Resident Mesenchymal Stem Cells Promote Repair of LPS-Induced Acute Lung Injury via Regulating the Balance of Regulatory T cells and Th17 cells , 2018, Inflammation.
[41] J. Laffey,et al. Syndecan-2–positive, Bone Marrow–derived Human Mesenchymal Stromal Cells Attenuate Bacterial-induced Acute Lung Injury and Enhance Resolution of Ventilator-induced Lung Injury in Rats , 2018, Anesthesiology.
[42] Patty J. Lee,et al. Effects of bone marrow‐derived mesenchymal stromal cells on gene expression in human alveolar type II cells exposed to TNF‐α, IL‐1β, and IFN‐γ , 2018, Physiological reports.
[43] Joonhong Park,et al. Expression profile of microRNAs following bone marrow-derived mesenchymal stem cell treatment in lipopolysaccharide-induced acute lung injury. , 2018, Experimental and therapeutic medicine.
[44] A. Arsenijević,et al. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[45] S. Xiao,et al. Human amnion-derived mesenchymal stem cells alleviate lung injury induced by white smoke inhalation in rats , 2018, Stem Cell Research & Therapy.
[46] Xiangyu Zhang,et al. Nrf2 transfection enhances the efficacy of human amniotic mesenchymal stem cells to repair lung injury induced by lipopolysaccharide , 2018, Journal of cellular biochemistry.
[47] P. Pelosi,et al. Mesenchymal Stem Cells From Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome* , 2017, Critical care medicine.
[48] J. L. Rosa,et al. Mesenchymal stem cells improves survival in LPS‐induced acute lung injury acting through inhibition of NETs formation , 2017, Journal of cellular physiology.
[49] M. Ohtsuka,et al. Bone marrow‐derived mesenchymal stem cells propagate immunosuppressive/anti‐inflammatory macrophages in cell‐to‐cell contact‐independent and ‐dependent manners under hypoxic culture , 2017, Experimental cell research.
[50] Mel S. Lee,et al. Effective protection against acute respiratory distress syndrome/sepsis injury by combined adipose-derived mesenchymal stem cells and preactivated disaggregated platelets , 2017, OncoTarget.
[51] Liping Wang,et al. Human Mesenchymal Stem/Stromal Cells From Human Umbilical Cord Ameliorate Acute Respiratory Distress Syndrome in Rats: Factors to Consider. , 2017, Critical care medicine.
[52] Mel S. Lee,et al. Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis , 2017, Oncotarget.
[53] C. Xiang,et al. Transplantation of Menstrual Blood-Derived Mesenchymal Stem Cells Promotes the Repair of LPS-Induced Acute Lung Injury , 2017, International journal of molecular sciences.
[54] Ching-Hsiung Lin,et al. Mesenchymal Stem Cell Administration in Patients with Chronic Obstructive Pulmonary Disease: State of the Science , 2017, Stem cells international.
[55] Z. Su,et al. Serious adverse events of cell therapy for respiratory diseases: a systematic review and meta-analysis , 2017, Oncotarget.
[56] J. Laffey,et al. Cryopreserved, Xeno-Free Human Umbilical Cord Mesenchymal Stromal Cells Reduce Lung Injury Severity and Bacterial Burden in Rodent Escherichia coli–Induced Acute Respiratory Distress Syndrome , 2017, Critical care medicine.
[57] R. Cancedda,et al. Mesenchymal Stem Cell‐Derived Extracellular Vesicles as Mediators of Anti‐Inflammatory Effects: Endorsement of Macrophage Polarization , 2017, Stem cells translational medicine.
[58] Rong Zhang,et al. Therapeutic Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Acute Lung Injury Mice , 2017, Scientific Reports.
[59] I. Petrache,et al. Pulmonary Retention of Adipose Stromal Cells following Intravenous Delivery is Markedly Altered in the Presence of ARDS , 2016, Cell transplantation.
[60] C. Shimbori,et al. Human mesenchymal stem cells attenuate early damage in a ventilated pig model of acute lung injury. , 2016, Stem cell research.
[61] J. V. van Laar,et al. Stem cell transplantation and mesenchymal cells to treat autoimmune diseases. , 2016, Presse medicale.
[62] Yi Yang,et al. The Vascular Endothelial Growth Factors-Expressing Character of Mesenchymal Stem Cells Plays a Positive Role in Treatment of Acute Lung Injury In Vivo , 2016, Mediators of inflammation.
[63] P. Rocco,et al. Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases? , 2016, Stem Cell Research & Therapy.
[64] A. Monsel,et al. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases , 2016, Expert opinion on biological therapy.
[65] Z-W Liu,et al. A study on the role of apoptotic human umbilical cord mesenchymal stem cells in bleomycin-induced acute lung injury in rat models. , 2016, European review for medical and pharmacological sciences.
[66] D. Swerdlow,et al. Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014 , 2016, The American Journal of Pathology.
[67] Z-W Liu,et al. A study on the role of apoptotic human umbilical cord mesenchymal stem cells in bleomycin-induced acute lung injury in rat models , 2016 .
[68] Zhixin Liang,et al. Mesenchymal Stem Cell Conditioned Medium Promotes Proliferation and Migration of Alveolar Epithelial Cells under Septic Conditions In Vitro via the JNK-P38 Signaling Pathway , 2015, Cellular Physiology and Biochemistry.
[69] J. Laffey,et al. Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury , 2015, Intensive Care Medicine Experimental.
[70] A. Pourfathollah,et al. TNF-α modulates the immunosuppressive effects of MSCs on dendritic cells and T cells. , 2015, International immunopharmacology.
[71] R. Sandberg,et al. In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome , 2015, Stem cells translational medicine.
[72] Qi Hao,et al. Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice. , 2015, American journal of respiratory and critical care medicine.
[73] Q. Hao,et al. Study of Bone Marrow and Embryonic Stem Cell‐Derived Human Mesenchymal Stem Cells for Treatment of Escherichia coli Endotoxin‐Induced Acute Lung Injury in Mice , 2015, Stem cells translational medicine.
[74] J. Laffey,et al. Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat , 2015, Thorax.
[75] B. Ni,et al. Sodium Butyrate Promotes the Differentiation of Rat Bone Marrow Mesenchymal Stem Cells to Smooth Muscle Cells through Histone Acetylation , 2014, PloS one.
[76] E. Geissler,et al. Conversion of Th17 into IL-17Aneg Regulatory T Cells: A Novel Mechanism in Prolonged Allograft Survival Promoted by Mesenchymal Stem Cell–Supported Minimized Immunosuppressive Therapy , 2014, The Journal of Immunology.
[77] P. Ran,et al. Mesenchymal stem cells suppress T cells by inducing apoptosis and through PD-1/B7-H1 interactions. , 2014, Immunology letters.
[78] M. Behari,et al. Fibroblast Growth Factor-2 alone as an efficient inducer for differentiation of human bone marrow mesenchymal stem cells into dopaminergic neurons , 2014, Journal of Biomedical Science.
[79] F. Qi,et al. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin. , 2014, Transplant immunology.
[80] D. Prough,et al. Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia , 2014, Thorax.
[81] H. Yoon,et al. B7-H1 inhibits T cell proliferation through MHC class II in human mesenchymal stem cells. , 2014, Transplantation proceedings.
[82] Assmaa O. Selim,et al. Mesenchymal stromal cell injection protects against oxidative stress in Escherichia coli-induced acute lung injury in mice. , 2014, Cytotherapy.
[83] Q. Shu,et al. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study , 2014, Respiratory Research.
[84] So Hee Park,et al. Intratracheal Administration of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in a Patient with Acute Respiratory Distress Syndrome , 2014, Journal of Korean medical science.
[85] J. Galipeau,et al. IDO-Independent Suppression of T Cell Effector Function by IFN-γ–Licensed Human Mesenchymal Stromal Cells , 2014, The Journal of Immunology.
[86] N. Kaminski,et al. Activation of Human Mesenchymal Stem Cells Impacts Their Therapeutic Abilities in Lung Injury by Increasing Interleukin (IL)‐10 and IL‐1RN Levels , 2013, Stem cells translational medicine.
[87] F. Djouad,et al. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells , 2013, Stem Cell Research & Therapy.
[88] M. Rojas,et al. Infusion of freshly isolated autologous bone marrow derived mononuclear cells prevents endotoxin-induced lung injury in an ex-vivo perfused swine model , 2013, Stem Cell Research & Therapy.
[89] B. Thébaud,et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[90] T. Cai,et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. , 2012, Cell stem cell.
[91] D. Mougiakakos,et al. Multipotent mesenchymal stromal cells and the innate immune system , 2012, Nature Reviews Immunology.
[92] Steven J. Greco,et al. Mesenchymal Stem Cells Protect Breast Cancer Cells through Regulatory T Cells: Role of Mesenchymal Stem Cell-Derived TGF-β , 2010, The Journal of Immunology.
[93] M. Engelse,et al. Isolated human islets contain a distinct population of mesenchymal stem cells , 2010, Islets.
[94] C. Shao,et al. Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression , 2010, The Journal of Immunology.
[95] A. Trounson,et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. , 2009, The American journal of pathology.
[96] J. García-Verdugo,et al. Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. , 2009, Stem cells and development.
[97] L. Moretta,et al. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. , 2009, Blood.
[98] P. Martiat,et al. Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. , 2009, Cytotherapy.
[99] F. Montecucco,et al. Human Mesenchymal Stem Cells Inhibit Neutrophil Apoptosis: A Model for Neutrophil Preservation in the Bone Marrow Niche , 2008, Stem cells.
[100] F. Lanza,et al. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. , 2008, Cytotherapy.
[101] L. Fouillard,et al. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. , 2008, Cellular immunology.
[102] J. Rossignol,et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. , 2007, Blood.
[103] F. Djouad,et al. Mesenchymal Stem Cells Inhibit the Differentiation of Dendritic Cells Through an Interleukin‐6‐Dependent Mechanism , 2007, Stem cells.
[104] L. Moretta,et al. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. , 2006, Blood.
[105] S. Perez,et al. Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells , 2006, Stem cells.
[106] Diane P. Martin,et al. Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.
[107] Yi Zhang,et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. , 2005, Blood.
[108] E. Lam,et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. , 2005, Blood.
[109] M. Pittenger,et al. Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.
[110] Xin Li,et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.
[111] C. Carlo-Stella,et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.
[112] N. Fisk,et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. , 2001, Blood.